FDA Inspection 1098218 — Novocol Pharmaceutical Of Canada, Inc.
The FDA completed an inspection of Novocol Pharmaceutical Of Canada, Inc. on Jun 21, 2019 in Cambridge. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Jun 21, 2019
- Fiscal Year
- 2019
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Cambridge (Canada)
Additional details
Bioanalytical BA/BE